5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively.
5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively.
复制标题
5-甲酰胞嘧啶和 5-羟甲基尿嘧啶分别作为骨髓增生异常综合征 TET2 和 SF3B1 突变的替代标记。
DOI：
10.3324/haematol.2019.224030
复制
发表时间：
2020
期刊：
影响因子：
10.1
通讯作者：
Olinski,Ryszard
中科院分区：
文献类型：
--
作者：
Gackowski,Daniel;Gawronski,Maciej;Kerr,Cassandra;Radivoyevitch,Tomas;Zarakowska,Ewelina;Starczak,Marta;Abakir,Abdulkadir;Ruzov,Alexey;Maciejewski,JaroslawP;Olinski,Ryszard
